Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate
Name
Blankschtein_Enhancing transdermal.pdf
Size
479.08 KB
Format
Adobe PDF
Checksum (MD5)
d6e096f6d043aad2d740bb15f928014e
Author(s)
Seto, Jennifer E.
Blankschtein, Daniel
Langer, Robert
Lopez, Renata F. V.
Date Issued
October 2010
Journal
Biomaterials
Publisher
Elsevier
Citation
Lopez, Renata F.V., Jennifer E. Seto, Daniel Blankschtein, and Robert Langer. “Enhancing the Transdermal Delivery of Rigid Nanoparticles Using the Simultaneous Application of Ultrasound and Sodium Lauryl Sulfate.” Biomaterials 32, no. 3 (January 2011): 933–941.
Version
Author's final manuscript
Abstract
The potential of rigid nanoparticles to serve as transdermal drug carriers can be greatly enhanced by improving their skin penetration. Therefore, the simultaneous application of ultrasound and sodium lauryl sulfate (referred to as US/SLS) was evaluated as a skin pre-treatment method for enhancing the passive transdermal delivery of nanoparticles. We utilized inductively coupled plasma mass spectrometry and an improved application of confocal microscopy to compare the delivery of 10- and 20-nm cationic, neutral, and anionic quantum dots (QDs) into US/SLS-treated and untreated pig split-thickness skin. Our findings include: (a) ~0.01% of the QDs penetrate the dermis of untreated skin (which we quantify for the first time), (b) the QDs fully permeate US/SLS-treated skin, (c) the two cationic QDs studied exhibit different extents of skin penetration and dermal clearance, and (d) the QD skin penetration is heterogeneous. We discuss routes of nanoparticle skin penetration and the application of the methods described herein to address conflicting literature reports on nanoparticle skin penetration. We conclude that US/SLS treatment significantly enhances QD transdermal penetration by 500–1300%. Our findings suggest that an optimum surface charge exists for nanoparticle skin penetration, and motivate the application of nanoparticle carriers to US/SLS-treated skin for enhanced transdermal drug delivery.
MIT Department
Massachusetts Institute of Technology. Department of Chemical Engineering
Terms of Use
Creative Commons Attribution-Noncommercial-NoDerivatives
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.biomaterials.2010.09.060
